Your institution may have rights to this item. Sign in to continue.
Title
Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors 'A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome'.